Armata Pharmaceuticals, Inc. Common Stock ARMP
Analyst Ratings
- Consensus
- Buy — 2 Buy · 0 Hold · 0 Sell (2 analysts)
- Avg. Price Target
- $15.00 (+301.1% upside)
Key Stats
- Today's Range
- $3.56 – $3.81
- 50-Day Range
- $3.52 – $6.64
- 52-Week Range
- $2.40 – $16.34
- Volume
- 101K shs
- Average Volume
- 284K shs
- Market Cap
- $139.06 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.36%
- Days to Cover
- 1.00
About Armata Pharmaceuticals, Inc. Common Stock
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Related Stocks
Compare head-to-head: ARMP vs AMGN·ARMP vs MRNA·ARMP vs HALO·ARMP vs TWST
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.